Document is current
Any future updates will be listed below
-
Authors
Cutano, Valentina https://orcid.org/0000-0001-6235-1082
Chia, Ming Li
Wigmore, Eleanor M. https://orcid.org/0000-0003-0864-9990
Hopcroft, Lorna https://orcid.org/0000-0003-3689-7609
Williamson, Stuart C. https://orcid.org/0000-0002-5209-4796
Christie, Amanda L.
Willis, Brandon
Kerr, James
Ashforth, Jenny
Fox, Rhys
D’Arcy, Sophie
Bradshaw, Lauren
Blaker, Catherine
Eberlein, Cath https://orcid.org/0000-0002-7357-7789
Montava-Garriga, Lambert
de Bruin, Elza C. https://orcid.org/0000-0002-8996-8354
Critchlow, Susan E.
Brindle, Kevin M.
Barry, Simon T. https://orcid.org/0000-0002-8511-0588
Ros, Susana https://orcid.org/0000-0002-5451-1880
-
Funding
Funding for this research was provided by:
AstraZeneca
AstraZeneca, US
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 7 April 2025
First Online: 22 April 2025
Competing interests
: S.R., E.M.W, L.H., S.C.W, A.L.C, B.W., R.F., S.D.A, L.B., C.B., C.E., L.M.-G., J.K., E.D.B, S.E.C, S.T.B. declare no competing non-financial interests but the following competing financial interests: AstraZeneca employees and shareholders. VC declares no competing non-financial Interests but the following competing financial interests: fellowship of the AstraZeneca postdoc programme. All other authors declare no Competing Financial or Non-Financial Interests. This study was funded by AstraZeneca.
